Viewing Study NCT03567720


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT03567720
Status: UNKNOWN
Last Update Posted: 2023-06-01
First Post: 2018-06-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Sponsor: OncoSec Medical Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module